Smoking and Lung Cancer: Cellular and Molecular Differences between Smokers and Never-Smokers

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 1982

Special Issue Editors


E-Mail Website
Guest Editor
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, ul. Rudolfa Weigla 12, 53-114 Wrocław, Poland
Interests: flow cytometry; genetics; immunology; genotyping; autoimmune disease; HLA; MHC; lymphocytes; cells; biomedical science; single nucleotide polymorphism; natural killer; T lymphocytes; cancer; antigen-presenting machinery genes and molecules

E-Mail Website
Guest Editor
Department of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, Chałubińskiego 6a St, 50-368 Wrocław, Poland
Interests: cancer biology; cell proliferation; cancer biomarkers; tumor microenvironment; immunohistochemistry; histology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Smoking is a major risk factor for lung cancer, therefore lung cancer epidemiologic trends reflect the past trends of cigarette smoking to a great extent. Although lung cancer is strongly associated with cigarette smoking, nevertheless only about 15% of smokers get lung cancer, and also some never-smokers develop this malignancy. The proportion of never-smokers among Asian patients is higher than in Caucasians. Other environmental factors include air pollution:  occupational;  second-hand tobacco smoke; smog; cooking oil fumes, particularly in Asian women; smoke from domestic combustion for heating; and radon in uranium miners. Gender differences in prevalence and histology of lung cancer were observed, which may be explained by differences in lifestyle (including smoking behavior) and occupation as well as by a double dose of X chromosome containing the largest number of immune-related genes and micro-RNAs. There are significant histopathological differences between smokers and never-smokers. Expression of many genes is different in smoking versus never-smoking lung cancer patients. Polymorphisms of several genes have been found to be risk factors in never or light smokers but tended to be protective in heavy smokers. There are also differences in de novo gene mutations and their frequencies in smokers and never-smokers bearing lung cancer.

Prof. Dr. Piotr Kusnierczyk
Prof. Dr. Piotr Dzięgiel
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lung cancer
  • smokers versus never-smokers
  • histology
  • metabolism
  • genetics

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

18 pages, 544 KiB  
Article
The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer
by Joerg Lindenmann, Melanie Fediuk, Nicole Fink-Neuboeck, Iurii Mykoliuk, Elisabeth Taucher, Martin Pichler, Josef Smolle and Freyja Maria Smolle-Juettner
Cells 2023, 12(3), 480; https://doi.org/10.3390/cells12030480 - 2 Feb 2023
Viewed by 1330
Abstract
Chronic obstructive pulmonary disease (COPD) serves as risk factor for the development of lung cancer and seems to have a prognostic impact after surgery for non-small cell lung cancer (NSCLC). The aim was to investigate the impact of COPD and postoperative mucostasis on [...] Read more.
Chronic obstructive pulmonary disease (COPD) serves as risk factor for the development of lung cancer and seems to have a prognostic impact after surgery for non-small cell lung cancer (NSCLC). The aim was to investigate the impact of COPD and postoperative mucostasis on the long-term survival after resected NSCLC. We retrospectively reviewed the data from 342 patients with curatively resected NSCLC. The prognostic long-term impact of COPD and postoperative mucostasis on overall survival (OS), recurrence free survival (RFS) and cancer specific survival (CSS) was calculated using univariable and multivariable Cox regression analyses. We found that 52.3% suffered from COPD and 25.4% had postoperative mucostasis. COPD was significantly more common among smokers (59.9%) compared with non-smokers (21.3%), (p < 0.001). There was a significant relationship between COPD and postoperative mucostasis (p = 0.006) and between smoking and mucostasis (p = 0.023). Patients with postoperative mucostasis had a significantly worse OS (p < 0.001), RFS (p = 0.009) and CSS (p = 0.008). The present analysis demonstrated that postoperative mucostasis, but not COPD, was associated with both worse short- and long-term outcomes for OS, RFS and CSS in curatively resected NSCLC. Full article
Show Figures

Figure 1

Back to TopTop